ISV-305

DRUG3 trials

Sponsors

Sun Pharmaceutical Industries Limited

Conditions

Active, Symptomatic BlepharitisInflammation and Pain Associated With Cataract Surgery

Phase 3

Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects

CompletedNCT01543490

Sun Pharmaceutical Industries LimitedActive, Symptomatic Blepharitis

Start: 2018-03-30End: 2020-02-04Updated: 2021-11-19

2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery

CompletedNCT03192150

Sun Pharmaceutical Industries LimitedInflammation and Pain Associated With Cataract Surgery

Start: 2018-01-03End: 2019-11-18Updated: 2021-11-19

Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery

CompletedNCT03192137

Sun Pharmaceutical Industries LimitedInflammation and Pain Associated With Cataract Surgery

Start: 2018-01-30End: 2019-04-17Updated: 2021-11-19